AXGN (STOCKS)
Axogen, Inc. Common Stock
$45.490000
+0.920000 (+2.06%)
Prev close: $44.570000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Michael D. Dale
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,384.49M
- Employees
- 452
- P/E (TTM)
- -70.79
- P/B (TTM)
- 9.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.07 | $0.07 | -0.0033 | -4.50% |
|
Dec 2025 (Q4)
|
$0.07 | $0.10 | -0.0291 | -29.36% |
|
Sep 2025 (Q3)
|
$0.12 | $0.07 | +0.0469 | +64.16% |
|
Jun 2025 (Q2)
|
$0.12 | $0.06 | +0.0554 | +85.76% |
Financial Statements
| Revenues | $238.11M |
| Benefits Costs and Expenses | $187.63M |
| Cost Of Revenue | $59.50M |
| Costs And Expenses | $187.63M |
| Gross Profit | $178.61M |
| Nonoperating Income/Loss | -$22.43M |
| Operating Expenses | $187.63M |
| Research and Development | $34.31M |
| Other Operating Expenses | $153.32M |
| Operating Income/Loss | -$9.02M |
| Income/Loss From Continuing Operations After Tax | -$31.45M |
| Income/Loss From Continuing Operations Before Tax | $50.48M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$31.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.63 |
| Diluted Earnings Per Share | -$0.64 |
| Basic Average Shares | 144,294,391 |
| Diluted Average Shares | 148,805,967 |
| Assets | $289.49M |
| Current Assets | $184.71M |
| Inventory | $46.07M |
| Other Current Assets | $138.63M |
| Noncurrent Assets | $104.78M |
| Intangible Assets | $7.27M |
| Other Non-current Assets | $97.51M |
| Liabilities | $44.68M |
| Current Liabilities | $26.01M |
| Noncurrent Liabilities | $18.67M |
| Equity | $244.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $244.81M |
| Liabilities And Equity | $289.49M |
| Net Cash Flow From Operating Activities | $15.56M |
| Net Cash Flow From Operating Activities, Continuing | $15.56M |
| Net Cash Flow From Investing Activities | -$22.62M |
| Net Cash Flow From Investing Activities, Continuing | -$22.62M |
| Net Cash Flow From Financing Activities | $67.62M |
| Net Cash Flow From Financing Activities, Continuing | $67.62M |
| Net Cash Flow | $60.56M |
| Net Cash Flow, Continuing | $60.56M |
| Comprehensive Income/Loss | -$31.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.45M |
| Other Comprehensive Income/Loss | $0.00 |